Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Reinhardt

Showing results (131-140 of 223) with videos related to

Pageof 23
Sort By:
Iscience|September 28, 2023
Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus <i>MYNRL15</i>Michelle Ng, Lonneke Verboon, Hasan Issa, et al.
Frontiers in Immunology|April 25, 2022
Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological MalignanciesMaren Soldierer, Arthur Bister, Corinna Haist, et al.
Genes, Chromosomes & Cancer|August 31, 2004
Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemiaMarkus Metzler, Pamela L Strissel, Reiner Strick, et al.
Haematologica|June 13, 2015
Recurrent deletions of IKZF1 in pediatric acute myeloid leukemiaJasmijn D E de Rooij, Eva Beuling, Marry M van den Heuvel-Eibrink, et al.
Blood|May 25, 2013
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, et al.
Pediatric Blood & Cancer|June 10, 2017
Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groupsUrsula Creutzig, Michael N Dworzak, Martin Zimmermann, et al.
British Journal of Haematology|March 17, 2020
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemiaKristian Løvvik Juul-Dam, Hans B Ommen, Charlotte G Nyvold, et al.
Cancers|March 6, 2021
Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study GroupMareike Rasche, Emma Steidel, Martin Zimmermann, et al.
Blood|June 21, 2003
FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistanceChristian M Zwaan, Soheil Meshinchi, Jerald P Radich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2024
Influence of Nucleophosmin (<i>NPM1</i>) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup CollaborationClaudia Tregnago, Maddalena Benetton, Rhonda E Ries, et al.
Pageof 23

Showing results (131-140 of 223) with videos related to

Sort By:
Pageof 23
Iscience|September 28, 2023
Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus <i>MYNRL15</i>Michelle Ng, Lonneke Verboon, Hasan Issa, et al.
Frontiers in Immunology|April 25, 2022
Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological MalignanciesMaren Soldierer, Arthur Bister, Corinna Haist, et al.
Genes, Chromosomes & Cancer|August 31, 2004
Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemiaMarkus Metzler, Pamela L Strissel, Reiner Strick, et al.
Haematologica|June 13, 2015
Recurrent deletions of IKZF1 in pediatric acute myeloid leukemiaJasmijn D E de Rooij, Eva Beuling, Marry M van den Heuvel-Eibrink, et al.
Blood|May 25, 2013
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, et al.
Pediatric Blood & Cancer|June 10, 2017
Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groupsUrsula Creutzig, Michael N Dworzak, Martin Zimmermann, et al.
British Journal of Haematology|March 17, 2020
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemiaKristian Løvvik Juul-Dam, Hans B Ommen, Charlotte G Nyvold, et al.
Cancers|March 6, 2021
Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study GroupMareike Rasche, Emma Steidel, Martin Zimmermann, et al.
Blood|June 21, 2003
FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistanceChristian M Zwaan, Soheil Meshinchi, Jerald P Radich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2024
Influence of Nucleophosmin (<i>NPM1</i>) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup CollaborationClaudia Tregnago, Maddalena Benetton, Rhonda E Ries, et al.
Pageof 23